Biotech Investors & VC Firms in China

202 firms in this list, with a median first check of $1.1M. 30 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
IN INP Capital JGNBJCSX6 people	88🔒	Vancouver	CA	Seed–Late Stage	—	+ Add to CRM
BL Black Marble Capital Management RCJHACFC12 people	88🔒	Taipei	TW	Seed–Late Stage	—	+ Add to CRM
WE Westlake International Group	88🔒	San Mateo	US	Pre-Seed–Series A	—	+ Add to CRM
SA Sahsen Ventures BWCWJLRH5 people	88🔒	Seattle	US	Pre-Seed–Series A	—	+ Add to CRM
RO Rockley Group ARRRZX3 people	88🔒	Oxford	GB	Growth	—	+ Add to CRM
PA PacBridge Capital Partners JLSTEWHB5 people	88🔒	Hong Kong	HK	Seed–Growth	—	+ Add to CRM
IN Infinity Group AGAS2 people	88🔒	Tel Aviv	IL	Growth	$1M – $10M	+ Add to CRM
TR Trinity Innovation Bioventure Singapore TKJZDX3 people · Follows rounds	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
MA Majuven LHLTLYHK4 people	88🔒	Singapore	SG	Seed–Late Stage	—	+ Add to CRM
SY Syno Capital, LLC JXJRDXJW4 people	88🔒	New York	US	Series A	—	+ Add to CRM
HO Hotung Investment Holdings Ltd.	88🔒	Singapore	SG	Series A–Late Stage	$300K – $1.5M	+ Add to CRM
JA JAFCO Group	88🔒	Tokyo	JP	Pre-Seed–Late Stage	$1.9M – $198M	+ Add to CRM
DA Darwin Venture Management	88🔒	Taipei	TW	Seed–Late Stage	$1M – $76M	+ Add to CRM
AI AIS CAPITAL BCJR2 people	88🔒	Tokyo	JP	Seed–Growth	—	+ Add to CRM
TC TCG Labs JCLY2 people	88🔒	San Francisco	US	—	—	+ Add to CRM
LA Lanchi Ventures JT1 person · Follows rounds	88🔒	Singapore	SG	Pre-Seed–Series A	—	+ Add to CRM
CA CARELA Holding GmbH	88🔒	Hamburg	DE	—	—	+ Add to CRM
ST Stonebridge Ventures HKDCSW3 people	88🔒	Seoul	KR	Seed–Late Stage	$743K – $33M	+ Add to CRM
VI Virtus Inspire Ventures TXVLALLL7 people	88🔒	—	HK	Seed–Series A	—	+ Add to CRM
BI Biomark Capital DLJZBESA4 people	88🔒	Greenwich	US	Series A–Late Stage	$5M – $10M	+ Add to CRM
VI Vincera Capital HCRS2 people	88🔒	Taipei	TW	Seed–Late Stage	$500K – $10M	+ Add to CRM
JA Japan Asia Investment SM1 person	88🔒	Tokyo	JP	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
10 10x Genomics ASJSPCDJ4 people	88🔒	Pleasanton	US	—	—	+ Add to CRM
CD CDIB Capital	88🔒	Hong Kong	HK	Series A–Series C	$1.5M – $100M	+ Add to CRM

INP Capital

VancouverSeed–Late Stage

JGNBJCSX6 people

Black Marble Capital Management

TaipeiSeed–Late Stage

RCJHACFC12 people

Westlake International Group

San MateoPre-Seed–Series A

Sahsen Ventures

SeattlePre-Seed–Series A

BWCWJLRH5 people

Rockley Group

OxfordGrowth

ARRRZX3 people

PacBridge Capital Partners

Hong KongSeed–Growth

JLSTEWHB5 people

Infinity Group

Tel AvivGrowth$1M – $10M

AGAS2 people

Trinity Innovation Bioventure Singapore

SingaporeSeed–Late Stage

TKJZDX3 people

Majuven

SingaporeSeed–Late Stage

LHLTLYHK4 people

Syno Capital, LLC

New YorkSeries A

JXJRDXJW4 people

Hotung Investment Holdings Ltd.

SingaporeSeries A–Late Stage$300K – $1.5M

JAFCO Group

TokyoPre-Seed–Late Stage$1.9M – $198M

Darwin Venture Management

TaipeiSeed–Late Stage$1M – $76M

AIS CAPITAL

TokyoSeed–Growth

BCJR2 people

TCG Labs

San Francisco

JCLY2 people

Lanchi Ventures

SingaporePre-Seed–Series A

JT1 person

CARELA Holding GmbH

Hamburg

Stonebridge Ventures

SeoulSeed–Late Stage$743K – $33M

HKDCSW3 people

Virtus Inspire Ventures

Seed–Series A

TXVLALLL7 people

Biomark Capital

GreenwichSeries A–Late Stage$5M – $10M

DLJZBESA4 people

Vincera Capital

TaipeiSeed–Late Stage$500K – $10M

HCRS2 people

Japan Asia Investment

TokyoPre-Seed–Late Stage$1M – $10M

SM1 person

10x Genomics

Pleasanton

ASJSPCDJ4 people

CDIB Capital

Hong KongSeries A–Series C$1.5M – $100M

Data sourced from public filings and firms' own websites — see our methodology.